Zoetis Inc. Files 8-K on Material Agreements

TL;DR

Zoetis 8-K: New deals in, old deals out, money obligations created. Details TBD.

AI Summary

On August 27, 2025, Zoetis Inc. filed an 8-K report indicating the entry into and termination of material definitive agreements, as well as the creation of direct financial obligations. The filing does not specify the parties involved in these agreements or the financial details of the obligations.

Why It Matters

This filing signals significant corporate actions, including potential new financial commitments and the dissolution of existing ones, which could impact Zoetis's financial structure and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates material definitive agreements were entered into and terminated, and financial obligations were created, suggesting significant, though unspecified, corporate activity.

Key Players & Entities

• Zoetis Inc. (company) — Registrant
• August 27, 2025 (date) — Date of report

FAQ

From the Filing

0001193125-25-189772.txt : 20250827 0001193125-25-189772.hdr.sgml : 20250827 20250827162154 ACCESSION NUMBER: 0001193125-25-189772 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250827 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250827 DATE AS OF CHANGE: 20250827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 251265520 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 8-K 1 d24666d8k.htm 8-K 8-K false 0001555280 0001555280 2025-08-27 2025-08-27     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 27, 2025     Zoetis Inc. (Exact name of registrant as specified in its charter)       Delaware   001-35797   46-0696167 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   10 Sylvan Way , Parsippany , New Jersey   07054 (Address of principal executive offices)   (Zip Code) (973) 822-7000 (Registrant’s telephone number, including area code) Not Applicable (Former Name or Former Address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   ZTS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01. Entry into a Material Definitive Agreement. Revolving Credit Facility On August 27, 2025, Zoetis Inc. (the “Company”) entered into a revolving credit agreement (the “Credit Agreement”) with a syndicate of banks, JPMorgan Chase Bank, N.A., as administrative agent, and Barclays Bank PLC, Bank of America, N.A., Citibank, N.A. and MUFG Bank, Ltd., as syndication agents, providing for a five-year $1.25 billion senior unsecured revolving credit facility. The Credit Agreement replaced t